Aurobindo gets tentative US FDA nod for migraine drug

Savings calculator | Retirement planner | Portfolio manager | Currency converter | Glitter estimator
Companies' quote in alphabetical order:
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

�

Sensex� | �Stocks last searched� | �Imagegallery� | �Other Utilities

�

BULLION RATES IN METROS

Cities	Gold (10g)
Chennai	Rs. 16415.00
Mumbai	Rs. 16275.00
Delhi	Rs. 16510.00
Kolkatta	Rs. 16560.00

Cities	Silver (1Kg)
Chennai	Rs. 24980.00
Mumbai	Rs. 24990.00
Delhi	Rs. 24500.00
Kolkatta	Rs. 24900.00

GLITTER ESTIMATOR

Calculate the Price of Gold/silver in the major metros. To calculate the price of gold/silver,enter the weight and purity of your selection.

Choose any metal
Nearest city

Weight (in gms)

Rupees

Sify Home>>Finance>>Equity>>Aurobindo gets tentative US FDA nod for migraine drug

Comments

| Share

| Print

| Rate

BUSINESS LINE

Aurobindo gets tentative US FDA nod for migraine drug

2008-02-01 18:11:20

Mumbai: Aurobindo Pharma Ltd has announced on Friday that it has received tentative approval from the US Food & Drug Administration (US FDA) to manufacture and market sumatriptan succinate tablets of 25 mg, 50 mg and 100 mg strengths.

Sumatriptan succinate tablets are the generic equivalent of GlaxoSmithKline's Imitrex(R) tablets, which are indicated for the treatment of acute migraines.